These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9178029

  • 1. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults.
    Saito H, Hosoi E, Yamasaki R, Kameyama K, Irahara M, Ohno Y, Saito S.
    Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029
    [Abstract] [Full Text] [Related]

  • 2. Secretory profile of immunoreactive growth hormone-releasing hormone (IR-GHRH) during sleep in man and its clinical value.
    Saito H, Hosoi E, Saito S.
    Horm Metab Res; 1997 Sep; 29(9):422-6. PubMed ID: 9370108
    [Abstract] [Full Text] [Related]

  • 3. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P, Knip M, Lautala P, Leppäluoto J.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [Abstract] [Full Text] [Related]

  • 4. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F.
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [Abstract] [Full Text] [Related]

  • 5. Insulinhypoglycemia but not arginine infusion stimulates circulating plasma growth hormone-releasing hormone (GHRH) concentrations in children.
    Rosskamp R, Schmid G, Klumpp J, Tegeler A.
    Horm Metab Res; 1987 Sep; 19(9):434-6. PubMed ID: 3121486
    [Abstract] [Full Text] [Related]

  • 6. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R, Saito H, Sano T, Kameyama K, Yoshimoto K, Hosoi E, Matsumura M, Harada K, Saito S.
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [Abstract] [Full Text] [Related]

  • 7. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S, Yamasaki R, Miyazaki S, Saito H, Saito S.
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug 20; 63(8):934-46. PubMed ID: 3123283
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of growth hormone secretion in mild primary hyperparathyroidism.
    Coiro V, Volpi R, Capretti L, Finardi L, Magotti MG, Manfredi G, Chiodera P, Saccani Jotti G.
    Horm Res; 2004 Aug 20; 62(2):88-91. PubMed ID: 15249740
    [Abstract] [Full Text] [Related]

  • 9. Fetal and maternal plasma levels of immunoreactive somatostatin at delivery: evidence for its increase in the umbilical artery and its arterio-venous gradient in the feto-placental circulation.
    Saito H, Saito S, Sano T, Hosoi E, Saito H.
    J Clin Endocrinol Metab; 1983 Mar 20; 56(3):567-71. PubMed ID: 6130103
    [Abstract] [Full Text] [Related]

  • 10. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
    Donnadieu M, Evain-Brion D, Tonon MC, Vaudry H, Job JC.
    J Clin Endocrinol Metab; 1985 Jun 20; 60(6):1132-4. PubMed ID: 3923020
    [Abstract] [Full Text] [Related]

  • 11. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
    Saggese G, Cesaretti G, Giannessi N, Bracaloni C, Cinquanta L, Cioni C.
    J Clin Endocrinol Metab; 1992 Feb 20; 74(2):272-8. PubMed ID: 1346143
    [Abstract] [Full Text] [Related]

  • 12. The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man.
    Masuda A, Shibasaki T, Kim YS, Imaki T, Hotta M, Demura H, Ling N, Shizume K.
    J Clin Endocrinol Metab; 1989 Oct 20; 69(4):906-9. PubMed ID: 2506217
    [Abstract] [Full Text] [Related]

  • 13. Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.
    Hanew K, Tanaka A, Utsumi A.
    J Endocrinol Invest; 1998 Feb 20; 21(2):72-7. PubMed ID: 9585379
    [Abstract] [Full Text] [Related]

  • 14. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
    Hanew K, Utsumi A.
    Eur J Endocrinol; 2002 Feb 20; 146(2):197-202. PubMed ID: 11834428
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses.
    Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frölich M, Stokvis-Brantsma WH, Wit JM.
    J Clin Endocrinol Metab; 2001 Jun 20; 86(6):2459-64. PubMed ID: 11397840
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD, Dieguez C, Valcavi R, Koppeschaar HP, Scanlon MF.
    Clin Endocrinol (Oxf); 1994 Jan 20; 40(1):97-102. PubMed ID: 8306488
    [Abstract] [Full Text] [Related]

  • 17. Immunoreactive growth hormone-releasing hormone in rat placenta.
    Meigan G, Sasaki A, Yoshinaga K.
    Endocrinology; 1988 Aug 20; 123(2):1098-102. PubMed ID: 2899497
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
    Page MD, Dieguez C, Valcavi R, Edwards C, Hall R, Scanlon MF.
    Clin Endocrinol (Oxf); 1988 May 20; 28(5):551-8. PubMed ID: 3145820
    [Abstract] [Full Text] [Related]

  • 19. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
    Boizel R, Halimi S, Labat F, Cohen R, Bachelot I.
    J Clin Endocrinol Metab; 1987 Feb 20; 64(2):304-8. PubMed ID: 3098773
    [Abstract] [Full Text] [Related]

  • 20. Nocturnal release of immunoreactive growth hormone-releasing hormone and growth hormone in normal children.
    Tapanainen P, Rantala H, Leppäluoto J, Lautala P, Käär ML, Knip M.
    Pediatr Res; 1989 Nov 20; 26(5):404-9. PubMed ID: 2510118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.